US FDA Adds Generic Insights On How To Demonstrate Nanomaterials Quality
Executive Summary
Document sets final framework for assessing chemistry, manufacturing, controls and bioequivalence of a wide range of nanomaterials with new advice such as focusing analysis on the right therapeutic moiety.